Isolating/Expanding the Entire TIL Repertoire of Tumor-Reactive CD8 T Cells for Cell Therapy in H&N Cancer

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Sep 23 2022

Publication series

NameArticles, Abstracts, and Reports

Cite this